DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Signal Genetics LLC 

667 Madison Avenue
14th Floor
New York  New York  10065  U.S.A.
Phone: 212-486-0040 Fax: 212-319-3328


SEARCH JOBS










 Company News
Signal Genetics LLC (SGNL) Obtains New York State Approval For MyPRS® Multiple Myeloma Prognostic Test 6/30/2014 12:05:54 PM
Signal Genetics LLC (SGNL) Announces Closing Of Initial Public Offering Of 850,000 Shares Of Common Stock 6/24/2014 8:32:36 AM
New York's Signal Genetics LLC (SGNL) Prices IPO At $10 A Share 6/18/2014 7:40:38 AM
Med BioGene Announces Settlement Agreement for the Dismissal of Litigation With Signal Genetics LLC and Respira Health LLC 8/22/2013 7:07:06 AM
Med BioGene Update to Ongoing Signal Genetics LLC and Respira Lawsuit 2/25/2013 8:04:39 AM
Signal Genetics LLC to Buy ChipDX LLC to Gain Cancer Diagnostics 2/2/2012 10:35:19 AM
Signal Genetics LLC Announces Publication of Meta-Analysis of its Colon Cancer Test-Previstage(TM) GCC Confirming Prognostic Capabilities in Patients with Colon Cancer 1/24/2012 9:20:59 AM
Signal Genetics LLC Announces Launch of Next Generation Genetic Multiple Myeloma Predictive Testing Product-MyPRS Plus(TM) 12/9/2011 10:45:21 AM
Signal Genetics LLC and DiagnoCure (CUR) Announce a US $13.3 Million Collaboration for the Commercialization of Previstage(TM) GCC Colorectal Cancer Staging Test 6/29/2011 7:01:02 AM
Signal Genetics LLC Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test 5/26/2011 4:54:49 PM
12